Penumbra (MEX:PEN) Research & Development: MXN1,649 Mil (TTM As of Mar. 2026)


MEX:PEN Penumbra Inc MEX:PEN
89 GF Score
Price MXN4,775.70
GF Value MXN4,981.98
! 1 Warning Sign
View Full Analysis

What is Penumbra Research & Development?

Penumbra MEX:PEN 89 Research & Development is MXN1,649 Mil as of Mar. 2026. GuruFocus rates MEX:PEN with a GF Score™ of 89/100 and a GF Value™ of MXN4,981.98. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Penumbra's Research & Development for the three months ended in Mar. 2026 was MXN404 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was MXN1,649 Mil.

Penumbra  (MEX:PEN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Penumbra Research & Development Related Terms

Penumbra Research & Development Historical Data

* Premium members only.

The historical data trend for Penumbra's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Penumbra Research & Development Chart

Penumbra Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,144.78 1,548.12 1,433.02 1,976.77 1,616.30

Penumbra Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 451.66 437.18 415.99 392.42 403.61
MEX:PEN
89GF Score
Penumbra Inc MEX:PEN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Penumbra Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN1,649 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MXN1,649 Mil mean?
Penumbra (MEX:PEN) has a Research & Development of MXN1,649 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Penumbra and its competitors.
Is Penumbra's Research & Development too high?
Penumbra's current Research & Development is MXN1,649 Mil. Overall, Penumbra has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Penumbra's Research & Development compare to GMED and PODD?
Penumbra's Research & Development of MXN1,649 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Penumbra and its competitors. Penumbra's current Research & Development is MXN1,649 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Penumbra stock overvalued right now?
Penumbra (MEX:PEN) has a current Research & Development of MXN1,649 Mil. The stock's GF Value™ is MXN4,981.98, compared to a current price of MXN4,775.70 — trading 4.1% below its estimated fair value. The current Research & Development is MXN1,649 Mil. Penumbra's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Penumbra (MEX:PEN), the current Research & Development is MXN1,649 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Penumbra (MEX:PEN) Overvalued in 2026?

Based on GuruFocus' analysis, Penumbra stock appears to be undervalued. The current stock price of MXN4,775.70 is trading 4.1% below its estimated GF Value™ of MXN4,981.98.

Key valuation signals for MEX:PEN:

  • Research & Development: MXN1,649 Mil
  • GF Value™: MXN4,981.98 vs. price of MXN4,775.70 (4.1% below fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the MEX:PEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Penumbra Business Description

Other Exchanges PEN:USA0P8:Germany
Address 1310 Harbor Bay Parkway, One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
89GF Score

Get the complete analysis for MEX:PEN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN4,775.70
Price
MXN4,981.98
GF Value